Garlicin attenuates reperfusion no-reflow in a catheter-based porcine model of acute myocardial infarction
Garlicin attenuates reperfusion no-reflow in a catheter-based porcine model of acute myocardial infarction
复制标题
DOI:
10.3109/10731199.2011.649187
复制
发表时间:
2012-08-01
期刊:
影响因子:
--
通讯作者:
Li Xianlun
中科院分区:
文献类型:
--
作者:
Yang Peng;Li Jiahui;Li Xianlun
Objective: To evaluate whether garlicin can attenuate reperfusion no-reflow in a catheter-based porcine model of acute myocardial infarction (AMI). Methods: Twenty-two swine were used: six in a sham-operation group, and eight each in the control and garlicin groups. The distal part of the left anterior descending coronary artery (LAD) in the latter two groups was occluded by a dilated balloon for 2 hr, then reperfused for 3 hr. Garlicin (1.88mg/kg) was injected just before reperfusion until reperfusion for 1 hr in the garlicin group. Hemodynamic data were examined before AMI, 2 hr after occlusion, and 3 hr after reperfusion. Myocardial contrast echocardiography (MCE) and pathological staining were performed to evaluate the myocardial no-reflow area (NRA). Serum proinflammatory cytokines and endothelin (ET)-1 were examined by radioimmunoassay. Results: Left ventricular systolic pressure (LVSP) and left ventricular end-diastolic pressure (LVEDP) significantly improved in the garlicin group after reperfusion compared with the control group and also 2hr after AMI (p